Brinda Balakrishnan
Director/Board Member bei AURINIA PHARMACEUTICALS INC.
Vermögen: 134 148 $ am 31.03.2024
Profil
Brinda Balakrishnan had a career history that included founding Vision Medicines, Inc. in 2013, where she held the title of VP-Corporate Strategy & Product Development from 2013 to 2016.
Currently, she is an Independent Director at Aurinia Pharmaceuticals, Inc. since 2021 and the Chief Business Development Officer & SVP at BioMarin Pharmaceutical, Inc. since 2016.
Dr. Balakrishnan has an educational background that includes undergraduate and doctorate degrees from the Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.05.2023 | 26 776 ( 0,02% ) | 134 148 $ | 31.03.2024 |
Aktive Positionen von Brinda Balakrishnan
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01.01.2016 |
| AURINIA PHARMACEUTICALS INC. | Director/Board Member | 14.06.2021 |
Ehemalige bekannte Positionen von Brinda Balakrishnan
| Unternehmen | Position | Ende |
|---|---|---|
Vision Medicines, Inc.
 Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Founder | 01.01.2016 |
Ausbildung von Brinda Balakrishnan
| Massachusetts Institute of Technology | Doctorate Degree |
| Harvard Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Vision Medicines, Inc.
Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Health Technology |
